February 14th 2023
Prevalence of IBD doubled between 1995 and 2016 and exposure to antibiotics may be to blame.
January 20th 2023
December 19th 2022
November 17th 2022
Inflammatory Bowel Disease Treatment Costs Reduced with IFX biosimilarAugust 26th 2022
Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.